APA (7th ed.) Citation

A, K., F, L., A, A., S, L., S, C., A, T., . . . H, H. (2024). Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria. American journal of hematology, 99(11), 2108. https://doi.org/10.1002/ajh.27456

Chicago Style (17th ed.) Citation

A, Kulasekararaj, et al. "Comparative Clinical Efficacy and Safety of Biosimilar ABP 959 and Eculizumab Reference Product in Patients with Paroxysmal Nocturnal Hemoglobinuria." American Journal of Hematology 99, no. 11 (2024): 2108. https://doi.org/10.1002/ajh.27456.

MLA (9th ed.) Citation

A, Kulasekararaj, et al. "Comparative Clinical Efficacy and Safety of Biosimilar ABP 959 and Eculizumab Reference Product in Patients with Paroxysmal Nocturnal Hemoglobinuria." American Journal of Hematology, vol. 99, no. 11, 2024, p. 2108, https://doi.org/10.1002/ajh.27456.